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Background
Sustained hyperglycaemia has been linked to the devel-
opment of chronic complications of type 1 diabetes
(T1D) in most populations, especially if it occurs in the
first few yrs. of the disease. However, this has been
poorly studied in the Brazilian multi-ethnic population.
Objectives
To assess if there is an association between the develop-
ment of chronic complications (retinopathy-DR, nephro-
pathy-DN, peripheral neuropathy– PN and cardiac
autonomic neuropathy-CAN) in patients with T1D and
1) the mean glycated Haemoglobin during their follow-
up since diabetes onset (mHbA1c); 2) the standard
deviation (SD) of HbA1c over this period, 3) the HbA1c
in the first 3 yrs. of disease (1st 3 yr.) and 4) the current
HbA1c.
Materials and methods
This retrospective study included patients with T1D ≥5 yrs.
that were followed in a specialized center. Epidemiological,
clinical and laboratory data were obtained by reviewing the
medical charts. mHbA1c, HbA1c in the 1st 3 yr of T1D
and SD of HbA1c were calculated. DR was evaluated by
ophthalmoscopy. Increased urinary albumin excretion
(IUAE) was defined according to the ADA criteria. CAN
was diagnosed through a Questionnaire and Variability of
heart rate tests. PN was defined by Neuropathy Symptoms
Score and Neuropathy Disability Scores.
Results
199 patients were assessed (54.7% women) with mean
age and T1D duration of 27.9±9.7, 17.1±7.3 yrs., respec-
tively. Their mean mHbA1c was 8.38±1.58%. DR, IUAE,
PN and CAN were seen in 10.8% (12/111), 17.7% (33/
188), PN in 35% (23/64) and CAN in 31.3% (33/107).
Patients with IUAE had higher mHbA1c levels than
others (8.95±1.53 vs. 7.99±1.18; p=0.010). MhbA1c also
differed between those with PN and others (9.12±1.82
vs. 7.65±0.93; p=0.001). Although there was no associa-
tion between mHbA1c and DR, the mean HbA1c in the
last 10 yrs. was higher in those with DR than others
(7.98±1.25 vs. 9.68±1.85; p=0.001). The SD of HbA1c
was also higher in those with DR and CAN than those
without these complications (p=0.004 and p=0.003,
respectively). The HbA1c 1st 3yr. was higher in patients
with DR (12.41±5.06 vs. 7.33±0.86; p=0.001) and in
those with DN (9.35±0.45 vs. 7.71±0.81; p=0.036) than
others. Current HbA1c (8.35±1.56) was not associated
with either of these complications.
Conclusions
Sustained hyperglycemia, especially in the first years of
the disease, and HbC1c variability over time have been
linked to the development of chronic complications in
our population.
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